{"title":"癌症患者与非癌症患者急性冠状动脉综合征诊断参数的比较:多因素分析","authors":"Anna Ciołek, Grzegorz Piotrowski","doi":"10.3390/curroncol31080357","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The simultaneous occurrence of cancer and acute coronary syndromes (ACSs) presents a complex clinical challenge. This study clarifies variances in diagnostic parameters among ACS patients with and without concurrent cancer.</p><p><strong>Methods: </strong>This retrospective study included 320 individuals diagnosed with ACS, stratified equally into two cohorts-one with cancer and the other cancer-free. We evaluated risk factors, symptom profiles, coronary angiography results, echocardiographic evaluations, and laboratory diagnostics. Statistical analysis was performed using Student's <i>t</i>-test, the Mann-Whitney U test, and the chi-square test.</p><p><strong>Results: </strong>Cancer patients were older (mean age 71.03 vs. 65.13 years, <i>p</i> < 0.001) and had a higher prevalence of chronic kidney disease (33.1% vs. 15.0%, <i>p</i> < 0.001) but a lower prevalence of hyperlipidemia (59.7% vs. 82.5%, <i>p</i> < 0.001). Chest pain was less frequent in cancer patients (72.5% vs. 90%, <i>p</i> < 0.001), while hypotension was more common (41.9% vs. 28.8%, <i>p</i> = 0.022). NSTEMI was more common in cancer patients (41.9% vs. 30.6%, <i>p</i> = 0.048), while STEMI was less common (20.6% vs. 45.3%, <i>p</i> < 0.001). RCA and LAD involvement were less frequent in cancer patients (RCA: 18.1% vs. 30.0%, <i>p</i> = 0.018; LAD: 18.8% vs. 30.0%, <i>p</i> = 0.026).</p><p><strong>Conclusions: </strong>This study demonstrates differences in the clinical presentation of ACS between patients with and without cancer. Cancer patients were less likely to present with chest pain and more likely to experience hypotension. Additionally, they had a higher prevalence of chronic kidney disease and they were less likely to have hyperlipidemia. These findings highlight the need for a careful approach to diagnosing ACS in oncology patients, considering their distinct symptomatology.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352875/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of Diagnostic Parameters of Acute Coronary Syndromes in Patients with and without Cancer: A Multifactorial Analysis.\",\"authors\":\"Anna Ciołek, Grzegorz Piotrowski\",\"doi\":\"10.3390/curroncol31080357\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The simultaneous occurrence of cancer and acute coronary syndromes (ACSs) presents a complex clinical challenge. This study clarifies variances in diagnostic parameters among ACS patients with and without concurrent cancer.</p><p><strong>Methods: </strong>This retrospective study included 320 individuals diagnosed with ACS, stratified equally into two cohorts-one with cancer and the other cancer-free. We evaluated risk factors, symptom profiles, coronary angiography results, echocardiographic evaluations, and laboratory diagnostics. Statistical analysis was performed using Student's <i>t</i>-test, the Mann-Whitney U test, and the chi-square test.</p><p><strong>Results: </strong>Cancer patients were older (mean age 71.03 vs. 65.13 years, <i>p</i> < 0.001) and had a higher prevalence of chronic kidney disease (33.1% vs. 15.0%, <i>p</i> < 0.001) but a lower prevalence of hyperlipidemia (59.7% vs. 82.5%, <i>p</i> < 0.001). Chest pain was less frequent in cancer patients (72.5% vs. 90%, <i>p</i> < 0.001), while hypotension was more common (41.9% vs. 28.8%, <i>p</i> = 0.022). NSTEMI was more common in cancer patients (41.9% vs. 30.6%, <i>p</i> = 0.048), while STEMI was less common (20.6% vs. 45.3%, <i>p</i> < 0.001). RCA and LAD involvement were less frequent in cancer patients (RCA: 18.1% vs. 30.0%, <i>p</i> = 0.018; LAD: 18.8% vs. 30.0%, <i>p</i> = 0.026).</p><p><strong>Conclusions: </strong>This study demonstrates differences in the clinical presentation of ACS between patients with and without cancer. Cancer patients were less likely to present with chest pain and more likely to experience hypotension. Additionally, they had a higher prevalence of chronic kidney disease and they were less likely to have hyperlipidemia. These findings highlight the need for a careful approach to diagnosing ACS in oncology patients, considering their distinct symptomatology.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-08-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352875/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/curroncol31080357\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol31080357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
背景:癌症和急性冠状动脉综合征(ACS)的同时发生给临床带来了复杂的挑战。本研究阐明了并发和未并发癌症的急性冠状动脉综合征患者在诊断参数上的差异:这项回顾性研究纳入了 320 名确诊为急性冠状动脉综合征的患者,将他们平均分为两组--一组患有癌症,另一组未患癌症。我们对风险因素、症状特征、冠状动脉造影结果、超声心动图评估和实验室诊断进行了评估。统计分析采用学生 t 检验、曼-惠特尼 U 检验和卡方检验:癌症患者年龄较大(平均年龄为 71.03 岁对 65.13 岁,P < 0.001),慢性肾脏病患病率较高(33.1% 对 15.0%,P < 0.001),但高脂血症患病率较低(59.7% 对 82.5%,P < 0.001)。癌症患者的胸痛发生率较低(72.5% 对 90%,P < 0.001),而低血压发生率较高(41.9% 对 28.8%,P = 0.022)。NSTEMI在癌症患者中更为常见(41.9% vs. 30.6%,p = 0.048),而STEMI则较少见(20.6% vs. 45.3%,p < 0.001)。癌症患者RCA和LAD受累的发生率较低(RCA:18.1% vs. 30.0%,p = 0.018;LAD:18.8% vs. 30.0%,p = 0.026):本研究显示了癌症患者和非癌症患者在 ACS 临床表现上的差异。癌症患者出现胸痛的可能性较小,而出现低血压的可能性较大。此外,癌症患者患有慢性肾病的比例较高,而患有高脂血症的比例较低。这些发现突出表明,考虑到肿瘤患者不同的症状,在诊断他们的 ACS 时需要采取谨慎的方法。
Comparison of Diagnostic Parameters of Acute Coronary Syndromes in Patients with and without Cancer: A Multifactorial Analysis.
Background: The simultaneous occurrence of cancer and acute coronary syndromes (ACSs) presents a complex clinical challenge. This study clarifies variances in diagnostic parameters among ACS patients with and without concurrent cancer.
Methods: This retrospective study included 320 individuals diagnosed with ACS, stratified equally into two cohorts-one with cancer and the other cancer-free. We evaluated risk factors, symptom profiles, coronary angiography results, echocardiographic evaluations, and laboratory diagnostics. Statistical analysis was performed using Student's t-test, the Mann-Whitney U test, and the chi-square test.
Results: Cancer patients were older (mean age 71.03 vs. 65.13 years, p < 0.001) and had a higher prevalence of chronic kidney disease (33.1% vs. 15.0%, p < 0.001) but a lower prevalence of hyperlipidemia (59.7% vs. 82.5%, p < 0.001). Chest pain was less frequent in cancer patients (72.5% vs. 90%, p < 0.001), while hypotension was more common (41.9% vs. 28.8%, p = 0.022). NSTEMI was more common in cancer patients (41.9% vs. 30.6%, p = 0.048), while STEMI was less common (20.6% vs. 45.3%, p < 0.001). RCA and LAD involvement were less frequent in cancer patients (RCA: 18.1% vs. 30.0%, p = 0.018; LAD: 18.8% vs. 30.0%, p = 0.026).
Conclusions: This study demonstrates differences in the clinical presentation of ACS between patients with and without cancer. Cancer patients were less likely to present with chest pain and more likely to experience hypotension. Additionally, they had a higher prevalence of chronic kidney disease and they were less likely to have hyperlipidemia. These findings highlight the need for a careful approach to diagnosing ACS in oncology patients, considering their distinct symptomatology.